# DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

> **NCT02976051** · PHASE2 · UNKNOWN · sponsor: **Danish Head and Neck Cancer Group** · enrollment: 60 (estimated)

## Conditions studied

- Locally Advanced Head and Neck Cancer
- Radiotherapy
- Hypoxic Radioresistance

## Interventions

- **RADIATION:** HART-CN

## Key facts

- **NCT ID:** NCT02976051
- **Lead sponsor:** Danish Head and Neck Cancer Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2021-06
- **Final completion:** 2022-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976051, "DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT02976051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*